Endocrine Society GUIDELINES Bundle (free trial)

Vitamin D for Prevention of Disease

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1522405

Contents of this Issue

Navigation

Page 3 of 7

Adults Aged ≥75 Years Recommendation 6 ➤ In the general population ages 75 years and older, we suggest empiric vitamin D supplementation because of the potential to lower the risk of mortality. (2| ⊕⊕⊕ ) Technical remarks: • Empiric vitamin D may include daily intake of fortified foods, vitamin formulations that contain vitamin D and/ or daily intake of a vitamin D supplement. • For empiric supplementation, daily, lower-dose vitamin D is preferred over non-daily, higher doses. • In the clinical trials included in the SR that reported on the mortality outcome, vitamin D dose ranged from 400 to 3333 IU (10 to 83 μg) daily equivalent. The estimated weighted average was approximately 900 IU (23 μg) daily. Participants in many trials were allowed to remain on their routine supplements, including up to 800 IU (20 μg) of vitamin D daily. Recommendation 7 ➤ In the general population ages 75 years and older, we suggest against routine testing for 25(OH)D levels. (2| ⊕ ) Technical remarks: • In this population, 25(OH)D thresholds that provide outcome-specific benefits have not been established in clinical trials. • The panel suggests against (a) routine screening for a 25(OH)D level to guide decision- making (i.e., vitamin D vs no vitamin D) and (b) routine follow-up testing for 25(OH) D level to guide vitamin D dosing. • This recommendation relates to generally healthy adults who do not otherwise have established indications for 25(OH)D testing (e.g., hypocalcemia). Pregnancy Recommendation 8 ➤ We suggest empiric vitamin D supplementation during pregnancy, given its potential to lower risk of preeclampsia, intra-uterine mortality, preterm birth, small for gestational age birth, and neonatal mortality. (2| ⊕⊕ ) Technical remarks: • This recommendation is based on evidence from trials conducted in healthy individuals during pregnancy. • Empiric vitamin D may include daily intake of fortified foods, prenatal vitamin formulations that contain vitamin D, and/ or a vitamin D supplement (pills or drops). • In the clinical trials included in the SR, the vitamin D doses ranged from 600 to 5000 IU (15 to 125 μg) daily equivalent, usually provided daily or weekly. The estimated weighted average was approximately 2500 IU (63 μg) per day.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Vitamin D for Prevention of Disease